YK11 是雄激素受体部分激动剂，当使用浓度为 0.1 μM 时，可激活过表达雄激素受体的 HEK293 细胞中的雄激素受体转录活性，具有成骨活性。

YK11 is an androgen receptor partial agonist that activates androgen receptor transcriptional activity in HEK293 cells overexpressing androgen receptors when used at a concentration of 0.1 μM, with osteogenic activity.

The induction of key myogenic regulatory factors (MRFs), such as myogenic differentiation factor (MyoD), myogenic factor 5 (Myf5) and myogenin, was more significant in the presence of YK11 than in the presence of DHT. YK11 treatment of C2C12 cells, but not DHT, induced the expression of follistatin (Fst), and the YK11-mediated myogenic differentiation was reversed by anti-Fst antibody. Suggest that the induction of Fst is important for the anabolic effect of YK11[1].

1370003-76-1

C25H34O6

430.541

(17ALPHA,20E)-17,20-[(1-甲氧基乙亚基)二(氧基)]-3-氧代-19-去甲孕甾-4,20-二烯-21-羧酸甲酯

DMSO:64 mg/mL (148.65 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years